View in EDS PDF Full Text

Cadherin-3 is a novel oncogenic biomarker with prognostic value in glioblastoma.

Saved in:
Bibliographic Details
Title: Cadherin-3 is a novel oncogenic biomarker with prognostic value in glioblastoma.
Authors: Martins EP; Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal.; ICVS/3B's - PT Government Associate Laboratory, Braga/Guimarães, Portugal., Gonçalves CS; Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal.; ICVS/3B's - PT Government Associate Laboratory, Braga/Guimarães, Portugal., Pojo M; Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal.; ICVS/3B's - PT Government Associate Laboratory, Braga/Guimarães, Portugal., Carvalho R; i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal., Ribeiro AS; i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal., Miranda-Gonçalves V; Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal.; ICVS/3B's - PT Government Associate Laboratory, Braga/Guimarães, Portugal., Taipa R; Neuropathology Unit, Department of Neurosciences, Centro Hospitalar do Porto, Porto, Portugal., Pardal F; Department of Pathology, Hospital de Braga, Portugal., Pinto AA; Department of Neurosurgery, Hospital de Braga, Portugal., Custódia C; Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Portugal., Faria CC; Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Portugal.; Neurosurgery Department, Hospital de Santa Maria, Centro Hospitalar Lisboa Norte (CHLN), Portugal., Baltazar F; Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal.; ICVS/3B's - PT Government Associate Laboratory, Braga/Guimarães, Portugal., Sousa N; Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal.; ICVS/3B's - PT Government Associate Laboratory, Braga/Guimarães, Portugal., Paredes J; i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal.; Faculty of Medicine of the University of Porto, Portugal., Costa BM; Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal.; ICVS/3B's - PT Government Associate Laboratory, Braga/Guimarães, Portugal.
Source: Molecular oncology [Mol Oncol] 2022 Jul; Vol. 16 (14), pp. 2611-2631. Date of Electronic Publication: 2022 Jun 10.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101308230 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-0261 (Electronic) Linking ISSN: 15747891 NLM ISO Abbreviation: Mol Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 34919784
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Cadherin-3 is a novel oncogenic biomarker with prognostic value in glioblastoma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Martins+EP%22">Martins EP</searchLink>; Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal.; ICVS/3B's - PT Government Associate Laboratory, Braga/Guimarães, Portugal.<br /><searchLink fieldCode="AU" term="%22Gonçalves+CS%22">Gonçalves CS</searchLink>; Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal.; ICVS/3B's - PT Government Associate Laboratory, Braga/Guimarães, Portugal.<br /><searchLink fieldCode="AU" term="%22Pojo+M%22">Pojo M</searchLink>; Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal.; ICVS/3B's - PT Government Associate Laboratory, Braga/Guimarães, Portugal.<br /><searchLink fieldCode="AU" term="%22Carvalho+R%22">Carvalho R</searchLink>; i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal.<br /><searchLink fieldCode="AU" term="%22Ribeiro+AS%22">Ribeiro AS</searchLink>; i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal.<br /><searchLink fieldCode="AU" term="%22Miranda-Gonçalves+V%22">Miranda-Gonçalves V</searchLink>; Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal.; ICVS/3B's - PT Government Associate Laboratory, Braga/Guimarães, Portugal.<br /><searchLink fieldCode="AU" term="%22Taipa+R%22">Taipa R</searchLink>; Neuropathology Unit, Department of Neurosciences, Centro Hospitalar do Porto, Porto, Portugal.<br /><searchLink fieldCode="AU" term="%22Pardal+F%22">Pardal F</searchLink>; Department of Pathology, Hospital de Braga, Portugal.<br /><searchLink fieldCode="AU" term="%22Pinto+AA%22">Pinto AA</searchLink>; Department of Neurosurgery, Hospital de Braga, Portugal.<br /><searchLink fieldCode="AU" term="%22Custódia+C%22">Custódia C</searchLink>; Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Portugal.<br /><searchLink fieldCode="AU" term="%22Faria+CC%22">Faria CC</searchLink>; Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Portugal.; Neurosurgery Department, Hospital de Santa Maria, Centro Hospitalar Lisboa Norte (CHLN), Portugal.<br /><searchLink fieldCode="AU" term="%22Baltazar+F%22">Baltazar F</searchLink>; Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal.; ICVS/3B's - PT Government Associate Laboratory, Braga/Guimarães, Portugal.<br /><searchLink fieldCode="AU" term="%22Sousa+N%22">Sousa N</searchLink>; Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal.; ICVS/3B's - PT Government Associate Laboratory, Braga/Guimarães, Portugal.<br /><searchLink fieldCode="AU" term="%22Paredes+J%22">Paredes J</searchLink>; i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal.; Faculty of Medicine of the University of Porto, Portugal.<br /><searchLink fieldCode="AU" term="%22Costa+BM%22">Costa BM</searchLink>; Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal.; ICVS/3B's - PT Government Associate Laboratory, Braga/Guimarães, Portugal.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101308230%22">Molecular oncology</searchLink> [Mol Oncol] 2022 Jul; Vol. 16 (14), pp. 2611-2631. <i>Date of Electronic Publication: </i>2022 Jun 10.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22John+Wiley+%26+Sons%2C+Inc%22">John Wiley & Sons, Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101308230 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1878-0261 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215747891%22">15747891 </searchLink><i>NLM ISO Abbreviation: </i>Mol Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34919784
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/1878-0261.13162
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 2611
    Titles:
      – TitleFull: Cadherin-3 is a novel oncogenic biomarker with prognostic value in glioblastoma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Martins EP
      – PersonEntity:
          Name:
            NameFull: Gonçalves CS
      – PersonEntity:
          Name:
            NameFull: Pojo M
      – PersonEntity:
          Name:
            NameFull: Carvalho R
      – PersonEntity:
          Name:
            NameFull: Ribeiro AS
      – PersonEntity:
          Name:
            NameFull: Miranda-Gonçalves V
      – PersonEntity:
          Name:
            NameFull: Taipa R
      – PersonEntity:
          Name:
            NameFull: Pardal F
      – PersonEntity:
          Name:
            NameFull: Pinto AA
      – PersonEntity:
          Name:
            NameFull: Custódia C
      – PersonEntity:
          Name:
            NameFull: Faria CC
      – PersonEntity:
          Name:
            NameFull: Baltazar F
      – PersonEntity:
          Name:
            NameFull: Sousa N
      – PersonEntity:
          Name:
            NameFull: Paredes J
      – PersonEntity:
          Name:
            NameFull: Costa BM
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 07
              Text: 2022 Jul
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 1878-0261
          Numbering:
            – Type: volume
              Value: 16
            – Type: issue
              Value: 14
          Titles:
            – TitleFull: Molecular oncology
              Type: main
ResultId 1